Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelines
- 31 August 1992
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 15 (6) , 537-543
- https://doi.org/10.1016/0732-8893(92)90105-3
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- In vitro activity evaluations of cefdinir (FK482, CI-983, and PD134393): A novel orally administered cephalosporinDiagnostic Microbiology and Infectious Disease, 1991
- Comparative in vitro activity and beta-lactamase stability of FK482, a new oral cephalosporinAntimicrobial Agents and Chemotherapy, 1989
- Antimicrobial activity, spectrum and pharmacokinetics of old and new orally administered cephemsAntimicrobic Newsletter, 1988
- Pharmacokinetics of FK482, a new orally active cephalosporin, in animals.The Journal of Antibiotics, 1988
- In vitro antibacterial activity of FK482, a new orally active cephalosporin.The Journal of Antibiotics, 1988
- FK 482, a new orally active cephalosporin. Synthesis and biological properties.The Journal of Antibiotics, 1988
- β-Lactam Antibiotics: Structural Relationships Affecting in Vitro Activity and Pharmacologic PropertiesClinical Infectious Diseases, 1986
- Comparative in vitro activity and beta-lactamase stability of FR 17027, a new orally active cephalosporinAntimicrobial Agents and Chemotherapy, 1984